AMH and Ovarian Reserve Testing: What the Number Means and What It Doesn't | Philadelphia

TL;DR30-second take

AMH, anti-Mullerian hormone, is a blood test that estimates how many eggs you have left, a measure of egg quantity rather than egg quality. It is a good predictor of how you would respond to IVF and a rough guide to how far you are from menopause, but for a woman who is not already facing infertility it does not reliably predict whether or how quickly she will conceive naturally. In a study of women aged 30 to 44 without a history of infertility, those with low AMH were about as likely to conceive within a year as those with normal levels. So a low AMH is not a verdict that you will struggle, and a high AMH is not a buffer against your age, because egg quality falls with age no matter what the number says. Direct-to-consumer fertility panels routinely overread AMH, and a test drawn while on the birth control pill reads falsely low. Where the number earns its keep is planning: in IVF or egg freezing it estimates how many eggs you might get per cycle. Age remains the main driver of fertility.

TL;DR: AMH, anti-Mullerian hormone, is a blood test that indexes the size of your remaining pool of growing follicles, which makes it a reasonable gauge of egg quantity and a poor gauge of anything else. It predicts how many eggs you would produce in an IVF or egg-freezing cycle, and it tracks, loosely, with how far off menopause is. What it does not do, for a woman who is not already struggling with infertility, is tell her whether she can conceive naturally or how long it will take. The clearest evidence for that comes from a study of women aged 30 to 44 with no history of infertility, where those with low AMH conceived within a year about as often as those with normal levels. That is why the major professional bodies say AMH should not be used to counsel presumed-fertile women about their fertility, in either direction: a low number is not a sentence, and a high number is not a reprieve from age, since egg quality declines with age regardless of the count. The direct-to-consumer fertility panels that sell AMH as a biological-clock readout routinely overstate it, and a result drawn while you are on the birth control pill reads falsely low. Where the number does help is logistics, estimating how many eggs a stimulation cycle might yield, which is a planning tool rather than a go-or-no-go fertility test. Age is the driver that matters most.

What is AMH, and what does it measure?

AMH is a hormone released by the granulosa cells that surround your small, early-stage follicles, the ones a few millimeters across that are gearing up but have not yet been selected for ovulation. Because those follicles come from the larger resting pool of eggs, the amount of AMH in your blood tracks how big that pool still is. In plain terms, it is a quantity gauge: a rough estimate of how many eggs you have left, which is what the phrase ovarian reserve means.

Two features make it convenient. It declines fairly predictably with age, becoming low and then undetectable in the years approaching menopause, and unlike the older FSH test, it stays fairly stable across the menstrual cycle, so it can be drawn on any day. Those conveniences are also where overconfidence takes hold. There is no single agreed-upon normal value, because the different laboratory methods do not measure AMH the same way; reported results can differ by a quarter to nearly half depending on the assay used.¹ A number that looks alarming from one lab might look ordinary from another. So the first thing to hold onto is that AMH is an estimate of egg quantity, read through an imperfect ruler, and quantity is only one piece of the fertility picture.

Does a low AMH mean I will struggle to get pregnant?

This is the question that sends people to the test, and the answer is the most misunderstood part of the topic. For a woman who is not already dealing with infertility, a low AMH does not reliably predict that she will have trouble conceiving naturally or that it will take longer.

The clearest evidence comes from a prospective study of women aged 30 to 44 with no history of infertility, who were tracked as they tried to conceive.² Women with a low AMH, below 0.7 nanograms per milliliter, were about as likely to be pregnant within six months and within a year as women with normal levels: by twelve cycles, roughly 84 percent of the low-AMH group had conceived, against about 75 percent of the normal group. A high early-cycle FSH, another reserve marker, told the same non-story. The reason is that AMH counts follicles, and conceiving in a given month depends far more on egg quality, which is governed by age, than on how many eggs remain. A 38-year-old with a healthy AMH still has 38-year-old eggs.

This is why the leading obstetrics and reproductive-medicine bodies say plainly that AMH should not be used to counsel women without a diagnosis of infertility about their fertility, and that a single value does not usefully predict time to pregnancy.³ ⁷ The evidence is still moving at the edges; a large 2024 cohort did find a modest link between low AMH and a slightly longer time to conceive, so the question is not fully closed. But the modest size of that signal does not overturn the main message: for a presumed-fertile woman, a low AMH is a reason to have a thoughtful conversation about age and goals rather than a reason to panic.

What is AMH good for?

None of this makes AMH useless. It makes it a test with a defined job and a set of jobs it cannot do, and the skill is telling them apart.

Where it performs well is predicting how your ovaries would respond to stimulation. In IVF and egg freezing, AMH, alongside an ultrasound follicle count, is among the best available predictors of how many eggs a stimulation cycle will yield, which is why fertility clinics use it to choose drug doses and set expectations.⁴ It also carries a population-level signal about the timing of menopause: lower age-adjusted levels tend to mean an earlier menopause, though the error around any individual prediction is wide enough that it cannot pin down a year for you. And it has a growing role in the assessment of polycystic ovary syndrome, where levels run two to several times higher than usual; the 2023 international PCOS guideline now allows a raised AMH to stand in for the ultrasound finding of many follicles when diagnosing the condition in adults, though not in adolescents, and the thresholds remain assay-specific.⁵ So the honest summary is that AMH is a planning and diagnostic aid inside fertility and hormone care, and a weak crystal ball everywhere else.

Should I trust a direct-to-consumer fertility hormone test?

The wellness market has turned AMH into a mail-order biological-clock reading, and that framing is where most of the harm happens. An analysis of direct-to-consumer AMH testing websites found that around three-quarters claimed the test predicts overall fertility and a similar share claimed it predicts menopause timing, claims the reviewers judged unsupported by the evidence.⁶

The harms run in both directions. A low result in a healthy 27-year-old can set off serious anxiety and push her toward expensive egg-freezing cycles or rushed life decisions she did not need to make. A high result in a 39-year-old can do the opposite, offering false comfort that there is plenty of time, when her age is steadily lowering egg quality no matter how many follicles she has. There is also a common technical trap: hormonal birth control lowers AMH temporarily, on the order of a fifth to a quarter, so a woman tested while on the pill can get a falsely low number that reverses within about a year of stopping.⁷ Add the lab-to-lab variability, and a single at-home number, read without context, can easily send someone in the wrong direction. The test is worth doing when there is a clinical reason and someone to interpret it; it is a poor purchase as a standalone fortune-teller.

What does AMH mean for egg freezing?

For the women reading this who are weighing egg freezing, AMH matters, but not in the way it is often sold. The dominant driver of whether frozen eggs become a baby is the age at which they were frozen, because age sets egg quality. AMH mainly tells you how many eggs a cycle is likely to produce, which affects how many cycles you may need, rather than whether freezing is worthwhile.

The numbers make the age point vividly. In a widely used counseling model, freezing about 20 mature eggs gave roughly a 90 percent chance of at least one live birth at age 34, around 75 percent at 37, and closer to 37 percent at 42, for the same number of eggs.⁸ Put another way, a younger woman needs fewer eggs to reach a good chance, while an older woman needs many more to reach the same odds, because each egg is less likely to succeed. That is why freezing earlier is the stronger move, and why a low AMH at a young age is not a reason to skip freezing, nor a high AMH at an older age a reason to feel covered. AMH helps you and a fertility specialist plan the number of cycles; age tells you how well those eggs are likely to work. And whatever the plan, there is a gap between eggs banked and a baby delivered, with no guarantees.

Can I raise my AMH?

The short answer is that AMH is mostly not something you can push upward in a way that changes your fertility, and being wary of products that promise otherwise will save you money and disappointment. The number tracks the biology of your follicle pool, and the biggest lever on it is one nobody controls: age, which lowers it steadily.

A few things lower AMH beyond age. Smoking reduces it, ovarian surgery and endometriosis can reduce it, and chemotherapy or pelvic radiation can lower it sharply, which is the basis for freezing eggs before cancer treatment. Birth control lowers it temporarily while you take it. On the other side, the supplements most often marketed to boost ovarian reserve, DHEA and CoQ10, have weak and mixed evidence confined mostly to lower-quality trials in women already in IVF for diminished reserve, and several trials of DHEA alone showed no benefit; any small rise in the AMH number may reflect measurement noise as much as a larger true egg pool. The practical stance is to treat AMH as a readout to interpret rather than a score to game, to stop smoking for many reasons including this one, and to make timing decisions based on your age and goals rather than on a hoped-for change in the number.

Guidance from the Clinic

"The pattern I see most is a healthy woman in her late twenties or thirties who ordered an AMH from a website, got a low number, and arrived frightened that she has run out of time. Almost always my first job is to take the panic down, because for a woman who is not struggling to conceive, that number does not predict whether she can get pregnant, and the research on this is clear. Then I ask two practical questions: how old are you, and are you on the pill, because the pill drags the number down and age is the thing that truly matters. Where I do take AMH seriously is planning. If we are talking about egg freezing or IVF, it tells us how many eggs a cycle might give us and how many rounds we might need, and that guides the plan. What I will not do is let a single mail-order number either scare a young woman into rushed decisions or lull an older one into thinking she has more time than her age allows. Read in context, it is a useful tool. Read alone, it misleads more often than it helps."

Key Takeaways

AMH estimates egg quantity, the size of your remaining follicle pool, read through an imperfect lab ruler; it is a measure of how many, not of how good, and egg quality is governed by age.
For a woman not already facing infertility, a low AMH does not reliably predict trouble conceiving naturally; in women aged 30 to 44 without infertility, low-AMH and normal-AMH groups conceived within a year at similar rates.
A high AMH is not a buffer against your age, and a low one is not a verdict; the professional societies advise against using AMH to counsel presumed-fertile women about their fertility in either direction.
AMH does useful work in planning: it predicts how many eggs an IVF or egg-freezing cycle will yield, gives a loose population signal for menopause timing, and helps assess PCOS; for egg freezing, age drives success and AMH estimates eggs per cycle.
Direct-to-consumer fertility panels overread AMH, a test drawn on the birth control pill reads falsely low, and supplements marketed to raise ovarian reserve have weak, mixed evidence, so interpret the number in context rather than treating it as a fortune-teller or a score to game.

Fertility Optimization and Pre-Conception Health - the fuller picture of preparing the body before conception
Preconception Planning: The 90-Day Runway - the practical timeline this fits into
Perimenopause Starts at 35 - what the years of declining reserve feel like and how to manage them
PCOS: A Metabolic Approach - where a high AMH fits the diagnosis
DHEA: A Clinical Guide - the honest evidence on a supplement often sold for ovarian reserve

Scientific References

Punchoo R, Bhoora S. "Variation in the Measurement of Anti-Mullerian Hormone: What Are the Laboratory Issues?" Frontiers in Endocrinology. 2021;12:719029.
Steiner AZ, Pritchard D, Stanczyk FZ, et al. "Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age." JAMA. 2017;318(14):1367-1376.
American College of Obstetricians and Gynecologists. "Committee Opinion No. 773: The Use of Antimullerian Hormone in Women Not Seeking Fertility Care." Obstetrics & Gynecology. 2019;133(4):e274-e278.
Broer SL, Dolleman M, van Disseldorp J, et al. "Added Value of Ovarian Reserve Testing on Patient Characteristics in the Prediction of Ovarian Response and Ongoing Pregnancy: An Individual Patient Data Approach." Human Reproduction Update. 2013;19(1):26-36.
Teede HJ, Tay CT, Laven J, et al. "Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome." Human Reproduction. 2023;38(9):1655-1679.
Johnson A, Thompson RE, Nickel B, et al. "Websites Selling Direct-to-Consumer Anti-Mullerian Hormone Tests." JAMA Network Open. 2023;6(8):e2330192.
Practice Committee of the American Society for Reproductive Medicine. "Testing and Interpreting Measures of Ovarian Reserve: A Committee Opinion." Fertility and Sterility. 2020;114(6):1151-1157.
Goldman RH, Racowsky C, Farland LV, et al. "Predicting the Likelihood of Live Birth for Elective Oocyte Cryopreservation: A Counseling Tool for Physicians and Patients." Human Reproduction. 2017;32(4):853-859.

Medical Disclaimer: This resource provides clinical context for educational purposes and is not medical advice. An AMH value cannot tell you whether you can conceive, and no single number should drive a major reproductive decision on its own. Do not start or stop contraception, supplements, or fertility treatment based on this article. In Precision Medicine there is no one-size-fits-all; how to read and act on ovarian reserve testing depends on your age, your goals, your medications, and your history. Consult Dr. Ash, your OB-GYN, or a reproductive endocrinologist about your fertility.

Fishtown Medicine | Hormones

2418 E York St, Philadelphia, PA 19125(267) 360-7927 hello@fishtownmedicine.comHSA/FSA Eligible

Start your intake

Frequently Asked Questions

Common Questions

No. AMH estimates how many eggs you have, which is different from whether you can conceive. In a study of women aged 30 to 44 without a history of infertility, those with low AMH were about as likely to conceive within a year as those with normal levels. Conceiving in a given month depends mostly on egg quality, which is set by your age, rather than on how many eggs remain. So a low AMH in a woman who is not already facing infertility is a reason for a thoughtful conversation about age and timing rather than a reason to conclude you will struggle.

Not in the way it sounds. A high AMH means you have a larger pool of eggs, but it says nothing about their quality, which falls with age no matter how high the number is. A 39-year-old with a reassuring AMH still has 39-year-old eggs. Reading a high number as a buffer against your biological clock is one of the more common and costly misreadings, because it can encourage delay that age does not forgive.

Be cautious. Direct-to-consumer panels often sell AMH as a fertility or menopause predictor, claims the professional societies do not support. A single number, read without context, can frighten a healthy young woman or falsely reassure an older one, and there are traps: different labs report different values, and being on the birth control pill lowers AMH temporarily. If you test, do it with a clinician who can put the number next to your age, your cycle, your medications, and your goals.

Hormonal contraception suppresses the ovarian activity that produces AMH, so your level drops while you are on it, commonly by about a fifth to a quarter. That means a test drawn on the pill can read falsely low and look like diminished reserve when it is not. The effect reverses, usually within about a year of stopping. If you want a meaningful AMH and you are on hormonal birth control, that context has to be part of reading the result.

When there is a clinical reason and someone to interpret it. It is useful in an infertility evaluation, in planning IVF or egg freezing where it predicts how many eggs a cycle may yield, in assessing polycystic ovary syndrome, and in counseling before cancer treatment that can harm the ovaries. In those settings it guides concrete decisions. What it is not good for is screening a presumed-fertile woman to forecast her fertility, which is how the mail-order versions tend to use it.

Deep-Dive Questions

Because the two questions are asking different things of the same follicle pool. IVF stimulation works by recruiting as many of your available small follicles as possible in one cycle, so a test that indexes the size of that pool, which is what AMH does, naturally predicts how many eggs you will get. Natural conception is a different problem: it depends on one egg each month being of high enough quality to fertilize, implant, and develop, and quality is governed by age-related changes inside the egg rather than by how many follicles are waiting in line. So AMH is well matched to the yield question and poorly matched to the quality question. A woman can have a modest follicle pool but young, healthy eggs, or a large pool of older eggs, and only the second question, quality, decides whether this month's attempt is likely to work.

Because AMH is measured by immunoassays, and the different commercial platforms are not calibrated to an identical standard. For years there was no universal reference method, and comparisons between the common assays showed results diverging by roughly a quarter to nearly half depending on which pair you compared. A reference reagent now exists and harmonization is improving, but it is not complete. The upshot is that there is no single validated cutoff for normal that holds across every lab, and a value that reads as low on one platform can read as unremarkable on another. This is a large part of why a bare number from a home kit, with no sense of which assay produced it or how it compares, is so easy to misread, and why interpretation belongs with the age and clinical context rather than against a one-size threshold.

Because freezing captures eggs at the quality they have on the day of retrieval, and that quality is stamped by age. The counseling models make this stark: the same 20 mature eggs give a roughly 90 percent chance of a live birth when frozen at 34 but closer to 37 percent when frozen at 42, because a far larger share of the older eggs carry chromosomal errors that keep them from becoming a healthy embryo. AMH influences the logistics, how many eggs you collect per cycle and therefore how many cycles you might need to reach a target, but it does not change the per-egg success rate, which age sets. That is why the advice is to freeze younger if you are going to, and why a low AMH is not a reason to skip freezing and a high AMH is not a reason to postpone it. The number that should drive urgency is the one on your birthday rather than the one on the lab report.

Mostly no, and it is worth being clear-eyed about it. The follicle pool you have is not meaningfully replenished, and AMH mostly reflects that biology, so the marketing promise of restoring reserve runs ahead of the science. The supplements most often sold for this, DHEA and CoQ10, have been studied mainly in women with diminished reserve going through IVF, in trials that are small and mixed, and DHEA on its own has failed to show benefit in several of them; where the AMH number ticks up, it is hard to separate a true effect from the assay's own noise. Smoking cessation is well worth doing, for ovarian and every other kind of health, but that prevents further harm rather than rebuilding what is there. The steady position is that AMH is something to interpret and plan around rather than a score you can train upward, and decisions about timing are better anchored to age and goals than to the hope of moving the number.

Ready when you are